An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
about
Individual patient data network meta-analysis of mortality effects of implantable cardiac devicesImage-guided left ventricular lead placement in cardiac resynchronization therapy for patients with heart failure: a meta-analysis.Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunctionWhy QRS Duration Should Be Replaced by Better Measures of Electrical Activation to Improve Patient Selection for Cardiac Resynchronization TherapyEffect of study design on the reported effect of cardiac resynchronization therapy (CRT) on quantitative physiological measures: stratified meta-analysis in narrow-QRS heart failure and implications for planning future studies2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theDevelopments in Cardiac Resynchronisation Therapy.Echocardiography and cardiac resynchronisation therapy, friends or foes?Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch BlockNovel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial.Assessment of cardiac resynchronisation therapy in patients with wide QRS and non-specific intraventricular conduction delay: rationale and design of the multicentre randomised NICD-CRT study.Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNPQRS duration versus morphology and survival after cardiac resynchronization therapy.Cardiac resynchronization therapy: the state of the art.Cardiac resynchronisation therapy in populations underrepresented in randomised controlled trials.Geometrical and electrical predictors of cardiac resynchronization therapy response.Multisite left ventricular pacing in cardiac resynchronization therapy.Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID(2) ): an evidence-based mnemonic for the treatment of systolic heartToward Sex-Specific Guidelines for Cardiac Resynchronization Therapy?Bridging the gap between heart failure and the device clinic.Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.Cardiac resynchronization therapy: results, challenges and perspectives for the future.Predictors of short-term clinical response to cardiac resynchronization therapy.Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).Role of echocardiography before cardiac resynchronization therapy: new advances and current developments.Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.Left Ventricular Size does not Modify the Effect of QRS Duration in Predicting Response to Cardiac Resynchronization Therapy.Endocardial left ventricular pacing for cardiac resynchronization: systematic review and meta-analysis.Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.Cardiac resynchronization therapy and its role in the management of heart failure.Novel Pacing Strategies for Heart Failure Management.The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.The role of electrocardiography in the elaboration of a new paradigm in cardiac resynchronization therapy for patients with nonspecific intraventricular conduction disturbance.Heart failure with reduced ejection fraction.Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure.Cardiac resynchronization therapy update: evolving indications, expanding benefit?New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT.
P2860
Q26798319-AECB56E1-544E-4B99-AE08-FF9056072746Q26863196-3B89B9C7-9747-4A64-B11D-D924C3BE9610Q27002918-F2EB74CC-46B5-4789-802E-9AB4B6B8A0BDQ28074580-A0488A32-A242-43EC-93C6-8CA320F37F5EQ28085449-B7344F69-AFC0-414C-AA93-A382E4CF6B0EQ28087002-6159BD7F-C7B6-4878-A644-E290F1D3BA73Q30392124-0327D4ED-1A5B-45A0-BFE1-EC90141EE325Q30394543-9832CD1A-63B2-4AB1-B824-AF893CCA42EBQ30777142-07CDC781-67C8-44F3-8CA6-901CC296E6CFQ36168804-55583522-46D1-49CA-9CF4-FA8D941C3770Q36307496-D6E8DB06-F231-4DE3-8E38-F01BDC4A89BEQ37454970-566F415A-55D0-486E-BEA5-F03E9C2F1A9DQ37520567-F1E2545A-13C7-472D-9125-EE70FF447D8EQ37625580-7C660B3C-912F-4DFF-A2AF-3C81570C8AE8Q38205885-6240B5FD-C028-4967-88C0-5F744664E571Q38210973-92965067-F6AF-431A-A2E2-351F472FB3B4Q38213563-90B4E63B-B30C-4694-8E83-69722D7AAF6AQ38258658-EFE0EEA1-484B-4231-BB7F-9DA6A2AC36E4Q38373981-84BE6F42-4325-4DA1-A983-5C4337AC7782Q38537344-3C7B3A1F-4E93-4B84-A6FF-55A0AA13ABC6Q38667272-90E718BA-2241-478A-98B5-AFE41FA9A412Q38682924-B5D8D80E-DC33-459D-A54E-C7414A660AF7Q38793773-E3D9E707-C436-4519-A2CB-7E8D5C450CA6Q38826268-3EA230A6-ED95-416B-BD98-005B4D56A01DQ38906544-B47ACC85-1BFC-4193-8560-4C34ECF1B1C7Q38930948-6B02D36B-BCD1-4A1B-9BC6-C7CC95D6B472Q38937383-542AC9A8-8356-40C9-9869-35ECD80A2FECQ38972837-C118D435-E548-4CF1-B094-84F943C23547Q38977548-8435B12C-9457-4A67-AD26-DB71AD63DEFDQ39078525-B4816E62-1936-457E-93EF-FA1CCB0B5D10Q39141583-7E041684-8F19-467D-B8BA-5006B902708BQ39373350-DD15C165-17FE-4746-BD42-FECA06FE1A70Q39451518-8C211C3C-D9AE-4FEE-A116-76A0F7CEED12Q39752243-18772DB4-F211-47EC-AF80-E50CB440FAEBQ39774479-E0F298D9-3050-4F75-96BC-2A3D4399912AQ40081533-908CAD39-AA3C-4284-98E7-D5CC5BCD6E7DQ40378100-9515114C-B72C-4697-903A-7C8BB6DBCBB4Q40616564-1CDF96FC-37F8-494D-BEF6-4A9CD386E6B3Q40684670-35CBA13E-CD72-49DD-928C-C446B59060D3Q40690348-6BD98026-2ED1-41F8-BE14-C0349000B2A6
P2860
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An individual patient meta-ana ...... ith symptomatic heart failure.
@en
An individual patient meta-ana ...... ith symptomatic heart failure.
@nl
type
label
An individual patient meta-ana ...... ith symptomatic heart failure.
@en
An individual patient meta-ana ...... ith symptomatic heart failure.
@nl
prefLabel
An individual patient meta-ana ...... ith symptomatic heart failure.
@en
An individual patient meta-ana ...... ith symptomatic heart failure.
@nl
P2093
P2860
P31
P921
P356
P1476
An individual patient meta-ana ...... ith symptomatic heart failure.
@en
P2093
Anthony S L Tang
George A Wells
J Claude Daubert
James B Young
John G Cleland
Lou Sherfesee
Michael R Gold
William T Abraham
P2860
P304
P356
10.1093/EURHEARTJ/EHT290
P5008
P577
2013-07-29T00:00:00Z
2013-12-01T00:00:00Z